WO2014162592A1 - 血液バッグシステム - Google Patents
血液バッグシステム Download PDFInfo
- Publication number
- WO2014162592A1 WO2014162592A1 PCT/JP2013/060484 JP2013060484W WO2014162592A1 WO 2014162592 A1 WO2014162592 A1 WO 2014162592A1 JP 2013060484 W JP2013060484 W JP 2013060484W WO 2014162592 A1 WO2014162592 A1 WO 2014162592A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- blood
- tube
- bag
- blood bag
- bag system
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0209—Multiple bag systems for separating or storing blood components
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3622—Extra-corporeal blood circuits with a cassette forming partially or totally the blood circuit
- A61M1/36222—Details related to the interface between cassette and machine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3622—Extra-corporeal blood circuits with a cassette forming partially or totally the blood circuit
- A61M1/36226—Constructional details of cassettes, e.g. specific details on material or shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3622—Extra-corporeal blood circuits with a cassette forming partially or totally the blood circuit
- A61M1/36226—Constructional details of cassettes, e.g. specific details on material or shape
- A61M1/362265—Details of valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3693—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/029—Separating blood components present in distinct layers in a container, not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/12—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit
Definitions
- the present invention relates to a blood bag system that is used in a blood product device for centrifuging blood and transfers a predetermined separated blood component.
- component blood transfusion has been performed in which components of blood (whole blood) obtained by donating blood are separated to provide only the components required by the patient. According to the component transfusion, the burden on the circulatory system and side effects can be reduced for the patient, and the donated blood can be effectively used.
- a light supernatant (platelet-poor plasma) fraction, a heavy sediment (concentrated red blood cell) fraction, and a buffy coat formed therebetween are centrifuged by a centrifuge. These components are transferred to a predetermined storage bag using a blood bag system that can be attached to the centrifuge.
- a blood bag system disclosed in US Pat. No. 6,910,998 has a blood bag for storing blood, a tube connected at one end to the blood bag, and a storage bag connected at the other end of the tube. .
- the centrifuged supernatant liquid (supernatant fraction) is transferred from the blood bag to a storage bag through a tube.
- the blood bag system attached to the centrifuge device as described above has a function of storing blood in the blood bag by blood donation or the like (or before centrifuging) so that the blood diffuses into the storage bag. Some amount of blood is transferred to the extending tube.
- the blood thus transferred does not particularly affect the quality of blood components even if mixed with the supernatant liquid flowing through the tube, for example.
- the color of whole blood red blood cells
- the user or the like may feel that the quality of the blood product is low even if only a small amount of blood is mixed.
- the present invention has been made in view of the above circumstances, and with a simple configuration, it is possible to greatly suppress mixing of other components with a predetermined blood component that has been centrifuged, thereby enabling high-quality blood. It is an object of the present invention to provide a blood bag system that can obtain a preparation, for example, a plasma preparation that is free from red blood cell contamination.
- the present invention includes a blood bag to which centrifugal force is applied in a state where whole blood or blood components are stored, and a tube through which a fluid centrifuged from the blood bag is circulated.
- the tube has an extending portion that extends in a direction substantially orthogonal to the centrifugal direction to which the centrifugal force is applied, and the extending portion has an extension portion in the centrifugal direction side.
- a storage portion capable of storing the fluid existing in the container is provided.
- the blood bag system includes the accommodating portion on the centrifugal direction side of the extending portion, thereby moving the fluid in the extending portion in the centrifugal direction by applying centrifugal force, and causing the fluid to flow into the accommodating portion. be able to. Therefore, at the time of centrifugation, for example, even if blood is present in the extending portion of the tube for transferring plasma, it is possible to satisfactorily accommodate blood subjected to centrifugal force. As a result, the inconvenience of blood being mixed with plasma can be greatly suppressed, and plasma can be transported well. Thereby, the blood bag system can obtain a high-quality blood product (plasma).
- plasma blood product
- the accommodating portion is a branch tube extending in the centrifugal direction.
- the accommodating portion is a branch tube
- the branch tube acts along the centrifugal direction when a centrifugal force is applied. Therefore, the accommodating part can accommodate smoothly the fluid which exists in the extension part.
- the storage unit may be configured to be deformed to have a space capable of storing the fluid when the centrifugal force is applied to the fluid.
- the space of the accommodating portion is deformed by applying centrifugal force to the fluid, so that the fluid can be easily accommodated in the space. Moreover, if it is set as the structure which an accommodating part deform
- the extending portion and the accommodating portion are integrally formed.
- the fluid can be smoothly guided to the accommodating portion without leaking outside.
- the blood bag and the tube may be attached to a cassette when the centrifugal force is applied, and the extending portion and the accommodating portion may be held in the horizontal direction by the cassette.
- the extending portion and the accommodating portion are held in the horizontal direction by the cassette, when the centrifugal force is applied to the extending portion and the accommodating portion, the movement of the internal fluid can be favorably promoted.
- FIG. 2 is a perspective view of a blood product device that houses the blood bag system of FIG. 1.
- FIG. 3 is a perspective view showing a part of a centrifugal drum of the blood product device of FIG. 2.
- FIG. 3 is a partially exploded perspective view showing the insert unit of FIG. 2.
- It is a top view which shows the attachment relationship of the cassette and 1st tube of the blood bag system of FIG. 6A is a first plan sectional view for explaining the operation of the branch tube of FIG. 5,
- FIG. 6B is a second plan sectional view following FIG. 6A, and
- FIG. 6C is a third plan sectional view following FIG. 6B.
- FIG. 6A is a first plan sectional view for explaining the operation of the branch tube of FIG. 5
- FIG. 6B is a second plan sectional view following FIG. 6A
- FIG. 6C is a third plan sectional view following FIG. 6B.
- FIG. 8A is a cross-sectional view showing a housing part of a blood bag system according to a first modification
- FIG. 8B is a plan view showing a housing part of a blood bag system according to a second modification
- FIG. It is sectional drawing which shows the accommodating part of the blood bag system which concerns on a 3rd modification
- FIG. 8D is sectional drawing which shows the effect
- FIG. 9A is a cross-sectional view showing a storage part of a blood bag system according to a fourth modification
- FIG. 9A is a cross-sectional view showing a storage part of a blood bag system according to a fourth modification
- FIG. 9B is a cross-sectional view showing a storage part of a blood bag system according to a fifth modification
- FIG. It is sectional drawing which shows the accommodating part of the blood bag system which concerns on a 6th modification
- FIG. 9D is sectional drawing which shows the accommodating part of the blood bag system which concerns on a 7th modification.
- the blood bag system 10 can be applied to a blood product device 12 (centrifugation device), and each component of blood (whole blood) centrifuged by the blood product device 12 is transferred to a different bag for storage. Configured to do. Specifically, whole blood is separated by centrifugation into three components: plasma (supernatant), which is a light specific gravity component, buffy coat, which is a medium specific gravity component, and concentrated red blood cells (precipitate), which are heavy specific gravity components.
- plasma supernatant
- buffy coat which is a medium specific gravity component
- precipitate concentrated red blood cells
- the separated concentrated erythrocytes are those added to SAG-M (Saline Adenine Glucose Mannitol) solution (hereinafter referred to as RC-SAGM), which is an erythrocyte preservation solution, and concentrated erythrocytes from which leukocytes have been removed from this RC-SAGM (Leukocyte). It is stored separately as Reduced Red Cells Concentrates (hereinafter referred to as LR-RCC).
- SAG-M Seline Adenine Glucose Mannitol
- LR-RCC Reduced Red Cells Concentrates
- the blood bag system 10 includes a blood bag 14, a plasma bag 16, an RC-SAGM bag 18, and an LR-RCC bag 20.
- the bags are connected by a plurality of tubes (first to fourth tubes 22, 24, 26, 28) through which blood components can flow.
- the blood bag 14, the plasma bag 16, the RC-SAGM bag 18 and the LR-RCC bag 20 are laminated with flexible sheet materials, and the peripheral seals are fused (thermal fusion, high frequency fusion). Alternatively, they are bonded to form a bag.
- the material constituting the sheet material include soft resin products such as polyvinyl chloride and polyolefin.
- the first to fourth tubes 22, 24, 26, and 28 are made of transparent and flexible resin tubes.
- a clamp (not shown) is appropriately attached in the middle of the first to fourth tubes 22, 24, 26, and 28, and the flow paths of the first to fourth tubes 22, 24, 26, and 28 are opened and shut off as necessary. It is possible to do. For example, when the blood bag system 10 is sterilized and stored before use, each clamp is opened, and the inside of each bag is communicated to be in a uniform sterilized state.
- the blood bag 14 (first bag) is a bag used for storing whole blood or storing separated blood components when blood is collected from a donor.
- the blood bag 14 is provided with a buffy coat as a remaining component after whole blood is centrifuged as described later and plasma is transferred to the plasma bag 16 and concentrated erythrocytes to the RC-SAGM bag 18, respectively. Used for containment and storage. That is, the blood bag 14 serves both for storing whole blood before separation and for storing buffy coat after separation.
- a blood preservation solution having a blood anticoagulation function is placed in the blood bag 14.
- a blood preservation solution for example, a solution containing citric acid, phosphoric acid, and glucose (CPD: Citrate Phosphate Dextrose) can be suitably used.
- the blood bag 14 is attached to a cassette 34 that can be supported by hanging the blood bag 14.
- the cassette 34 is formed in a flat box shape having a wide surface shape and a predetermined thickness, and is attached to the insert unit 60 of the blood product device 12 described later.
- FIG. 1 a state in which one surface of the cassette 34 faces in the same direction as the blood bag 14 is illustrated, but in the centrifugal separation, the cassette 34 is tilted horizontally with respect to the blood bag 14 to be suspended. And attached to the insert unit 60.
- One end of the first tube 22 is connected to the upper part of the blood bag 14, and one end of the second tube 24 and one end of the blood collection tube 30 are connected to the lower part of the blood bag 14.
- the first tube 22 is a tube for transferring plasma that is a light specific gravity component. A part of the first tube 22 faces the upper side of the blood bag 14 and is fixedly held on a flat portion of the cassette 34. The first tube 22 extends freely from a predetermined position of the cassette 34, and the other end is connected to the plasma bag 16. Is done.
- the second tube 24 is a tube for transporting concentrated red blood cells, and one end of the second tube 24 is connected to the lower part of the blood bag 14 so that the concentrated red blood cells that are centrifugally separated specific gravity components can be delivered. Yes.
- the second tube 24 also extends upward from the lower portion of the blood bag 14, so that a part of the second tube 24 is fixed and held on the flat portion of the cassette 34, and extends in a free state from the position opposite to the first tube 22. -Connected to the SAGM bag 18;
- the blood collection tube 30 is a tube used at the time of blood collection in order to store the donor's whole blood in the blood bag 14.
- a clamp 36 that closes and opens the flow path of the blood collection tube 30 is provided in the middle of the blood collection tube 30 (proximal end side blood collection tube 30a).
- One end of a sealing member 38 (breaking communication member) is connected to the other end of the proximal end side blood collection tube 30a.
- the sealing member 38 is configured so that the flow path is opened by performing a breaking operation, although the flow path is closed in the initial state.
- the first port 40 a of the three-port connector 40 is connected to the other end of the sealing member 38.
- One end of a blood collection tube 30 (front end side blood collection tube 30b) is connected to the second port 40b of the 3-port connector 40, and a blood collection needle 42 is connected to the other end of the front end side blood collection tube 30b.
- the blood collection needle 42 is fitted with a cap 42a before use and a needle guard 42b after use.
- One end of the branch blood collection tube 44 is connected to the third port 40c of the 3-port connector 40.
- a clamp 46 that closes and opens the flow path of the branched blood collection tube 44 is provided in the middle of the branched blood collection tube 44.
- An initial blood bag 48 is connected to the other end of the branch blood collection tube 44.
- the sampling port 50 is connected to the initial blood bag 48, and by attaching a blood collection tube (not shown) to the sampling port 50, the initial blood collection flow is collected in the blood collection tube.
- the collected initial blood stream is used as test blood.
- the portion from the 3-port connector 40 to the sampling port 50 may be omitted.
- the plasma bag 16 (second bag) contains and stores the plasma transferred from the blood bag 14 by connecting the first tube 22 to the upper portion thereof.
- the RC-SAGM bag 18 (third bag) contains and stores concentrated erythrocytes transferred from the blood bag 14 by connecting the second tube 24 to the upper part thereof.
- the RC-SAGM bag 18 contains SAGM, which is a mixed solution containing mannitol, glucose, adenine and sodium chloride, as described above, as a blood preservation solution having an anticoagulant function for concentrated erythrocytes.
- the LR-RCC bag 20 (fourth bag) is a bag for storing and storing the LR-RCC, and is connected to the RC-SAGM bag 18 via the third and fourth tubes 26 and 28.
- a filter 52 capable of removing white blood cells (predetermined components) is provided between the third tube 26 and the fourth tube 28, and the LR-RCC bag 20 has a concentrated white blood cell removed through the filter 52. Red blood cells (LR-RCC) are introduced.
- a sample tube 32 from which a part of the LR-RCC can be taken out is connected to the upper portion of the LR-RCC bag 20. That is, in the blood bag system 10, the state of LR-RCC can be confirmed.
- the blood bag system 10 is applied to, for example, a blood product device 12 as shown in FIG.
- This blood product device 12 centrifuges whole blood contained in a blood bag 14 and divides it into three layers of plasma, buffy coat and concentrated erythrocytes, and transfers the plasma to the plasma bag 16 and also converts the concentrated erythrocytes to RC. Used for transfer to the SAGM bag 18
- the configuration of the blood product device 12 will be described below.
- the arrow A direction in FIG. 3 is the radial direction
- the arrow B direction is the circumferential direction.
- the circumferential direction is a direction along an arc as indicated by an arrow B.
- a direction orthogonal to the arrow A is also referred to as a circumferential direction in the explanation portion.
- the blood product device 12 has a box shape, and an upper lid 54 that can be opened and closed, an internal centrifugal drum 56 (centrifugation means), and an equal angle (60 °) within the centrifugal drum 56.
- Six unit insertion holes 58 provided at intervals, six insert units 60 inserted into each unit insertion hole 58, and six pushers provided at the center and capable of moving forward and backward with respect to each insert unit 60 62 (pressing means: see FIG. 3).
- the blood product device 12 operates based on the operation of the operation unit 64 provided on the front, is controlled by a microcomputer (not shown), and displays predetermined information on the monitor 66.
- the centrifugal drum 56 has a unit divided into six along the circumferential direction, and is configured to rotate at a predetermined speed. Whole blood contained in the blood bag 14 is separated by applying a centrifugal force according to the rotation of the centrifugal drum 56.
- the center body 68 and the unit insertion hole 58 are integrally formed in one unit.
- the center body 68 is provided with a holding lever 70, an electrode 72, a first rod 74, a second rod 76, and a pusher 62.
- the holding lever 70 is urged by an elastic body (not shown) and holds the end of the cassette 34.
- the electrode 72 When the insert unit 60 is inserted into the unit insertion hole 58, the electrode 72 is electrically connected to a detection sensor (not shown) provided on the base 90 (see FIG. 4) of the insert unit 60.
- the detection sensor individually detects plasma flowing through the first tube 22 and concentrated red blood cells flowing through the second tube 24 and transmits the detection signal to the blood product device 12.
- the blood product device 12 can discriminate the circulation state (timing of distribution start or distribution end) of the centrifuged blood component based on this detection signal.
- the first and second rods 74 and 76 are provided so as to advance and retract in the radial direction A, respectively.
- the first and second rods 74 and 76 on the first circumferential direction B1 side constitute first clamp driving means 78 that opens and closes the first clamp mechanism 102 (see FIG. 4) of the cassette 34.
- the first and second rods 74 and 76 on the second circumferential direction B2 side constitute second clamp driving means 80 for opening and closing the second clamp mechanism 110 (see FIG. 4).
- the pusher 62 has a function of pressing the blood bag 14 during centrifugation by being provided on the inner wall of the unit insertion hole 58 in the inner diameter direction A2 so as to be able to advance and retract in the radial direction A. Plasma and concentrated red blood cells separated in the blood bag 14 are discharged from the blood bag 14 by applying the pressing force.
- the insert unit 60 includes a unit main body 82 and a cover body 84.
- the unit main body 82 is a bottomed cylinder having a wide arc shape in plan view and an open top surface.
- the unit main body 82 has a small chamber 86 on the inner diameter side (hereinafter referred to as a first chamber 86) and a large chamber 88 on the outer diameter side by partitioning the inside of the cylinder by an arc-shaped wall 82a.
- the first chamber 86 is opened not only on the upper surface but also on the inner diameter side.
- a pedestal 90 projecting in the inner diameter direction A ⁇ b> 2 is provided on the inner diameter side upper portion of the first chamber 86, and the cassette 34 is attached to the upper surface of the pedestal 90.
- the large chamber 88 is divided into a second chamber 88a on the first circumferential direction B1 side and a third chamber 88b on the second circumferential direction B2 side, with a wall 82b provided at a substantially central portion in the circumferential direction B interposed therebetween. Divided.
- the cassette 34 includes a cassette main body 92 that fixes and holds the tube, and a transparent lid (not shown) that is attached to the upper surface of the cassette main body 92.
- the cassette body 92 is formed so as to correspond to the center body 68 of the centrifugal drum 56 in a plan view (see FIG. 1) so that the outer diameter direction A1 side is wide and the inner diameter direction A2 is narrow.
- On both sides of the cassette body 92 in the circumferential direction B a pair of extending portions 94 that project a predetermined length in the outer diameter direction A1 are provided.
- an opening 92a that is long in the circumferential direction B is provided in the central portion of the cassette body 92, and the above-described detection sensor is inserted into the opening 92a.
- a first guide path 96 for guiding the first tube 22, a second guide path 98 for guiding the second tube 24, and two pins for supporting the blood bag 14 are provided on the upper surface of the cassette body 92.
- the first and second guide paths 96 and 98 are constructed by providing walls that can hold the first and second tubes 22 and 24 at a plurality of locations.
- the first guide path 96 is bent from the vicinity of the center of the outer diameter direction A1 end of the cassette 34 toward the inner diameter direction A2 and bent in the first circumferential direction B1 at a midway portion thereof. It extends from the bent portion 96a to the side surface of the cassette 34 in the first circumferential direction B1. Further, the first guide path 96 extends in the outer radial direction A1 along the side surface in the first circumferential direction B1, and reaches the end portion in the outer radial direction A1 of the extending portion 94 in the first circumferential direction B1. In the course of forming the groove in the circumferential direction B of the first guide path 96, a first clamp mechanism 102 for blocking and opening the flow path 22a of the first tube 22 is provided.
- the first clamp mechanism 102 includes a blocking piece 104 that can be elastically displaced in the radial direction A, a hooking piece 106 that can hook the blocking piece 104, and a tube support 108 that faces the blocking piece 104.
- the blocking piece 104 is formed with a substantially triangular contact portion 104a on the distal end side, and is displaced toward the outer diameter direction A1 when pressed by the first rod 74. Thereby, the contact part 104a can crush the 1st tube 22 in cooperation with the tube support part 108, and can interrupt
- the hook piece 106 is hooked to the tip of the contact portion 104a as the blocking piece 104 is displaced in the outer diameter direction A1.
- the 1st clamp mechanism 102 suppresses the elastic return to the internal diameter direction A2 side of the interruption
- the first clamp mechanism 102 is displaced in the first circumferential direction B1 when the convex portion 106a of the hook piece 106 is pressed by the second rod 76, and the engagement of the blocking piece 104 is released (that is, the first tube). 22 channels 22a are opened).
- the second guide path 98 is bent at an intermediate position from the outer diameter direction A1 end of the extending portion 94 of the cassette 34 in the second circumferential direction B2 toward the inner diameter direction A2. It extends in one circumferential direction B1. Further, the second guide path 98 is bent again toward the inner diameter direction A2 at a position (a position passing through the opening 92a) extending from the bent portion 98a by a predetermined length in the first circumferential direction B1, and thereafter It is formed so as to follow a path that is substantially symmetrical with one guide path 96.
- the second guide path 98 loops the right half on the cassette body 92 from the outer diameter direction A1 end portion of the extending portion 94 in the second circumferential direction B2, and the outer diameter direction A1 end of the same extending portion 94. To the department.
- a second clamp mechanism 110 for blocking and opening the flow path of the second tube 24 is provided. ing.
- the second clamp mechanism 110 is formed symmetrically with the first clamp mechanism 102.
- the cover body 84 is attached to the unit main body 82 from the outer surface.
- the cover body 84 covers the outer surface, the upper surface, and the lower surface of the unit main body 82, thereby reliably holding the blood bag system 10 attached to the unit main body 82.
- the insert unit 60 configured as described above is inserted into and attached to the centrifugal drum 56 (unit insertion hole 58) (see FIG. 2), whereby the blood product apparatus 12 performs centrifugation of whole blood.
- the blood bag system 10 is attached to the insert unit 60 in a state where each bag and each tube are connected (system construction state).
- the blood bag 14 storing the whole blood collected from the donor is attached to the cassette 34 and stored in the first chamber 86 of the unit main body 82.
- the cassette 34 is mounted on the pedestal 90 so as to be horizontal to the blood bag 14 (tilt by 90 °) and attached to the unit main body 82.
- the other bags (plasma bag 16, RC-SAGM bag 18, LR-RCC bag 20) have first to fourth tubes 22, 24, 26, and 28 connected to each other. In the state, it is accommodated in the large chamber 88 of the unit main body 82.
- the plasma bag 16 is accommodated in the second chamber 88a, and the RC-SAGM bag 18 and the LR-RCC bag 20 are accommodated in the third chamber 88b.
- the blood collection tube 30 is cut and sealed at a predetermined position (position close to the blood bag 14) during centrifugation.
- the first tube 22 is held by the first guide path 96, and the second tube 24 is held by the second guide path 98. Therefore, the 1st tube 22 is wired so that the extension part 112 extended toward 1st circumferential direction B1 may be exhibited on the 1st guide path 96, as shown in FIG. That is, the extending portion 112 corresponds to a range from the bent portion 96 a on the first guide path 96 to the first clamp mechanism 102. Since the cassette 34 is mounted horizontally with respect to the insert unit 60, the extending portion 112 extends horizontally on the plane (same height) of the cassette 34 and is orthogonal to the radial direction A of the centrifugal drum 56. Fixed to. Therefore, the extending part 112 is orthogonal to the direction (centrifugal direction) where centrifugal force is applied from the centrifugal drum 56.
- the whole blood when the whole blood is accommodated in the blood bag 14 (or after the whole blood is accommodated), as described above, the first tube 22 (extension portion) 112), the whole blood may move. That is, in the blood bag system 10, the first clamp mechanism 102 closes the first tube 22 and collects blood or the like. However, the blood bag system 10 diffuses with respect to the anticoagulant that has moved to the first tube 22, so that the first clamp mechanism 102 Whole blood enters the flow path 22 a of the first tube 22 up to 102.
- the extending portion 112 In the state where the whole blood is present in the extending portion 112, the extending portion 112 is orthogonal to the centrifugal direction, so that it extends without returning to the blood bag 14 even if a centrifugal force is applied during the centrifugation process. It remains in the portion 112. Then, when plasma is pushed out and circulated through the first tube 22 in the transfer step after the centrifugation step, it is mixed with the supernatant (plasma) and transferred to the plasma bag 16 (particularly, red blood cells flow into the plasma bag 16). Since inconvenience becomes a problem, what remains in the extending portion 112 is hereinafter referred to as red blood cell contamination C).
- a branch tube 114 (accommodating portion) is provided in the extending portion 112 of the first tube 22 in order to accommodate the erythrocyte contamination C at the time of centrifugation. That is, the branch tube 114 has a function of preventing the red blood cell contamination C from flowing into the plasma bag 16 by accommodating the red blood cell contamination C.
- the branch tube 114 is formed so as to be orthogonal to the extending portion 112 and extends in the centrifugal direction (outer diameter direction A1).
- the branch tube 114 is integrally formed with the extending portion 112 (that is, the first tube 22), and includes an accommodation space 116 having an inner diameter comparable to that of the extending portion 112.
- the entire length of the branch tube 114 is formed so that the accommodation space 116 has a volume capable of sufficiently accommodating the red blood cell contamination C.
- the branch tube 114 has a connecting end 118 connected to the extending portion 112, a body portion 120 that is connected to the connecting end 118, and an extending end 122 that is connected to the body portion 120 and is an end portion opposite to the connecting end 118. .
- the peripheral portion of the connection end 118 is fixed and held by a wall that forms the first guide path 96. Thereby, the angle of the branch tube 114 with respect to the extension part 112 can be easily maintained in the orthogonal direction (90 °).
- the extending end 122 is in a free state by the body portion 120 extending from the connecting end 118 without being particularly fixed and held. As described above, when the branch tube 114 is in a free state on the outer diameter direction A1 side with respect to the connection end 118, the extended end 122 can be easily along the centrifugal direction with the application of the centrifugal force.
- the branch tube 114 is preferably provided in the vicinity of the first clamp mechanism 102. Thereby, the red blood cell contamination C that has entered the vicinity of the first clamp mechanism 102 can be reliably transferred to the accommodation space 116.
- the extended end 122 of the branch tube 114 has a configuration in which air easily escapes while preventing the liquid from flowing out. Thereby, air can be extracted during centrifugation, and the transfer of the accommodation space 116 for the red blood cell contamination C can be facilitated.
- the blood bag system 10 is basically configured as described above, and its operation and effect will be described below based on a blood product generation procedure.
- each bag and tube are connected before blood collection by the donor, the blood bag 14 is attached to the cassette 34, and the first and second tubes 22 and 24 are wired.
- the initial blood collection is collected in the initial blood bag 48 as described above.
- the branch tube 114 is closed by the clamp 46, and the breaking operation described above is performed on the sealing member 38 to open the flow path of the blood collection tube 30.
- the clamp 36 keeps the blood collection tube 30 open, and the first and second clamp mechanisms 102 and 110 of the cassette 34 keep the flow paths of the first and second tubes 22 and 24 closed.
- the donor's blood (whole blood) flows into the blood bag 14 via the blood collection tube 30.
- the blood collection tube 30 is welded and sealed with a tube sealer or the like, and then cut at a portion where the blood collection tube 30 is sealed.
- the blood bag system 10 with the blood collection tube 30 cut is attached to the insert unit 60.
- the plasma bag 16 and the RC-SAGM bag 18 are not bent and are stored in the large chamber 88 (
- the plasma bag 16 may be accommodated in the second chamber 88a, and the RC-SAGM bag 18 may be accommodated in the third chamber 88b).
- the filter 52 and the LR-RCC bag 20 are not used in the centrifugation step and the subsequent transfer step, the filter 52 and the LR-RCC bag 20 are stored in the large chamber 88 after being compacted by rounding or bending. Thereby, the accommodation space for the plasma bag 16 and the RC-SAGM bag 18 can be secured.
- the insert unit 60 to which the blood bag system 10 is attached is inserted into the unit insertion hole 58 of the blood product device 12.
- the holding lever 70 fixes the end of the cassette 34.
- the detection sensor of the insert unit 60 or the contact of its interface circuit is electrically connected to the electrode 72.
- six insert units 60 are attached to the blood product device 12, but may be five or less (preferably three or two at equal intervals) as long as the balance is achieved.
- the whole blood (red blood cell contamination C) contained in the blood bag 14 can move to the flow path 22a of the first tube 22. There is sex. Although the movement of the red blood cell contamination C stops at the closed portion of the first tube 22 by the first clamping mechanism 102, the red blood cell contamination C remains in the flow path 22a of the extending portion 112 as shown in FIG. 6A.
- the red blood cell contamination C shown in FIGS. 6A to 6C shows a state in which a large amount is present in the extending portion 112 for easy understanding, but in practice, the red blood cell contamination in the extending portion 112 is present. It is a grade which C exists in a trace amount.
- the centrifuge process and the transfer process are automatically performed by operating the operation unit 64 after the lid 54 is closed.
- the centrifugal process is first performed by rotating the centrifugal drum 56.
- the first and second clamping mechanisms 102 and 110 are closed in advance, the first rod 74 is driven forward to press the blocking piece portion 104 for further certainty.
- the whole blood stored in the blood bag 14 is subjected to centrifugal force, so that concentrated erythrocytes of heavy specific gravity component move in the outer diameter direction, and plasma of light specific gravity component becomes inner diameter.
- the medium specific gravity component buffy coat moves in the middle and separates into three layers.
- the erythrocyte contamination C present in the extending part 112 receives a centrifugal force and moves so as to approach the outer diameter direction A1 side of the flow path 22a of the extending part 112.
- the red blood cell contamination C flows into the branch tube 114 from the extending portion 112, and the flowed red blood cell contamination C moves to the extending end 122 of the branch tube 114 along the centrifugal direction. .
- the branch tube 114 is provided at a position close to the first clamp mechanism 102, and can smoothly guide the erythrocyte contamination C in the extending portion 112 inclined obliquely with respect to the centrifugal direction. Therefore, by performing the centrifugation step, the red blood cell contamination C existing in the flow path 22a of the extending portion 112 is greatly reduced.
- the red blood cell contamination C is also present in the flow path 22a upstream of the extending portion 112 (bent portion 96a) of the first tube 22, but the red blood cell contamination C present in this portion is used for blood by applying centrifugal force. Move to bag 14.
- the blood product device 12 moves to the transfer step after the centrifugation step.
- the first and second clamp mechanisms 102 and 110 are operated to open the flow paths of the first and second tubes 22 and 24.
- the pusher 62 is displaced in the outer diameter direction A1, and the blood bag 14 is pressed. Since the volume of the blood bag 14 is reduced by being sandwiched between the pusher 62 and the wall, plasma flows out to the first tube 22 and concentrated red blood cells flow out to the second tube 24. At this time, since the first tube 22 is oriented toward the inner diameter side, the plasma positioned closest to the inner diameter side can be satisfactorily discharged from the blood bag 14. In addition, since the second tube 24 is directed to the outer diameter side, the concentrated red blood cells located on the outermost diameter side can be favorably discharged from the blood bag 14.
- plasma moves from the blood bag 14 to the extending portion 112 of the first tube 22 as shown in FIG. 6C.
- the red blood cell contamination C since the red blood cell contamination C has moved to the branch tube 114 in the centrifugation step, the red blood cell contamination C does not remain in the extending portion 112, and the plasma is not mixed with the red blood cell contamination C. 22 can be moved. As a result, high-purity plasma is stored in the plasma bag 16.
- the red blood cell contamination C acts in the outer diameter direction A1 by continuing to receive the centrifugal force during the transfer process. Therefore, at the initial stage of the transfer process, the remaining red blood cell contamination C can be washed away with plasma and transferred from the extending portion 112 to the branch tube 114.
- the blood bag system 10 is taken out from the insert unit 60. Further, each bag is separated by cutting the first tube 22 and the second tube 24 in the blood bag system 10 after welding and sealing. As a result, plasma is stored in the plasma bag 16, buffy coat is stored in the blood bag 14, and concentrated red blood cells are stored in the RC-SAGM bag 18. Part of the concentrated red blood cells stored in the RC-SAGM bag 18 is transferred to the LR-RCC bag 20 via the third tube 26, the filter 52, and the fourth tube 28. At this time, leukocytes are removed by the filter 52, so that the LR-RCC bag 20 is well accommodated in the LR-RCC bag 20.
- the blood bag system 10 when the centrifugal force is applied by providing the branch tube 114 (accommodating portion) on the centrifugal direction side of the extending portion 112, the extending portion 112 is provided.
- the red blood cell contamination C moves in the centrifugal direction. That is, the branch tube 114 can accommodate the red blood cell contamination C satisfactorily. Therefore, the first tube 22 can significantly suppress the mixing of red blood cell contamination C with the plasma to be transferred, and can transfer the plasma well. Thereby, the blood bag system 10 can obtain a high-quality blood product (plasma).
- the accommodating portion for red blood cell contamination C is formed in the branch tube 114 branched from the extending portion 112, so that the branch tube 114 acts along the centrifugal direction when centrifugal force is applied. Therefore, the branch tube 114 can smoothly accommodate the red blood cell contamination C present in the extending portion 112.
- the blood bag system 10 can guide the plasma and red blood cell contamination C to the branch tube 114 without leaking to the outside because the extending portion 112 and the branch tube 114 are integrally formed.
- the centrifugal force is applied to the extending portion 112 and the branch tube 114, the centrifugal force is well transmitted to the erythrocyte contamination C. Can be moved. That is, the red blood cell contamination C moves horizontally under the action of the centrifugal force and easily moves in the outer diameter direction A1, so that the branch tube 114 can be moved more smoothly.
- the blood bag system 10 is not limited to the above-described embodiment, and can of course have various configurations.
- some modified examples of the present invention will be described.
- symbol is attached
- the blood bag system 10A has a first tube 22 separated into an upstream tube 23a and a downstream tube 23b in the extending portion 112, and a branch tube 130 formed in a T shape.
- the connection end 132 is connected.
- the branch tube 130 may be formed as a separate member with respect to the extending portion 112.
- the straight first tube 22 can be cut and an assembling method can be adopted in which the branch tube 130 is inserted into the cut portion. After the first tube 22 is wired to the cassette 34, the branch tube 130 is It can be easily provided.
- the blood bag system 10B has a configuration in which two branch tubes 140 and 142 are provided for the extending portion 112 as shown in FIG. 8B.
- the two branch tubes 140 and 142 are provided at a position spaced apart from each other by a predetermined distance, for example, the first branch tube 140 is provided in the vicinity of the opening 92 a and the second branch tube 142 is provided in the vicinity of the first clamp mechanism 102.
- the blood bag system 10 can accommodate the red blood cell contamination C better by having the two branch tubes 140 and 142 in this way.
- the number of branch tubes provided in the extending portion 112 is not particularly limited.
- the blood bag system 10C has a membrane material 150 (accommodating portion) that can be elastically stretched on the side surface of the extending portion 112 of the first tube 22 in the outer diameter direction A1. It is the provided structure.
- the membrane material 150 is configured to swell in the centrifugal direction when the fluid in the extending portion 112 receives a centrifugal force, and the volume of the internal storage space 152 can be changed. Therefore, the membrane material 150 is in a contracted state as shown in FIG. 8C before the centrifugal separation, and when the red blood cell contamination C present in the extending portion 112 receives a centrifugal force, the red blood cell contamination C is stored in the accommodation space 152.
- the red blood cell contamination C can be stored well. Further, if the housing part (film material 150) is configured to be deformed, the placement location of the housing part on the cassette 34 can be freely set.
- the blood bag system 10D according to the fourth modification is configured such that the connecting portion 162 of the extending portion 112 and the branch tube 160 is narrow, and the branch tube 160 is expanded in the extending direction. ing. As described above, when the branch tube 160 is formed, it is possible to prevent the red blood cell contamination C moved to the accommodation space 164 of the branch tube 160 from flowing out again into the extending portion 112.
- the blood bag system 10E according to the fifth modification has a configuration in which a valve portion 174 is provided inside the connection end 172 of the branch tube 170, as shown in FIG. 9B.
- the valve part 174 has a function of a check valve, and is opened by the red blood cell contamination C that has been subjected to centrifugal force, so that the red blood cell contamination C can flow into the accommodation space 176 of the branch tube 170.
- the erythrocyte contamination C that has flowed into the accommodation space 176 is blocked from flowing out by blocking the valve portion 174 even if it tries to flow out again into the extending portion 112.
- the blood bag system 10F according to the sixth modification is formed in a bag portion 180 in which the accommodating portion for the red blood cell contamination C is opened relatively wide in the extending direction of the extending portion 112.
- the blood bag system 10G according to the seventh modification is formed in a bag 190 having a narrow neck 192 and a reservoir 194 having a relatively large volume.
- the shape of the accommodating portion for accommodating the red blood cell contamination C is not particularly limited, and various configurations can be taken.
- each bag and each tube can be attached to the blood product apparatus without using a cassette, and even in this case, the same effect as described above can be obtained by appropriately providing a branch tube (accommodating portion). Can do.
- the storage unit for storing blood is not only applied to a tube for transferring plasma, but of course can be applied to various tubes that receive centrifugal force.
Abstract
Description
Claims (5)
- 全血又は血液成分を貯留した状態で遠心力が付与される血液用バッグ(14)と、前記血液用バッグ(14)から遠心分離された流体を流通するチューブ(22)とを備える血液バッグシステム(10、10A~10G)であって、
前記チューブ(22)は、前記遠心力がかかる遠心方向に対し略直交方向に延在する延在部(112)を有し、
前記延在部(112)の前記遠心方向側には、該延在部(112)内に存在する流体を収容可能な収容部(114、130、140、142、150、160、170、180、190)が設けられる
ことを特徴とする血液バッグシステム(10、10A~10G)。 - 請求項1記載の血液バッグシステム(10、10A、10B、10D、10E)において、
前記収容部(114、130、140、142、160、170)は、前記遠心方向に延在する分岐チューブ(114、130、140、142、160、170)である
ことを特徴とする血液バッグシステム(10、10A、10B、10D、10E)。 - 請求項1記載の血液バッグシステム(10C)において、
前記収容部(150)は、前記遠心力が前記流体にかかることにより該流体を収容可能な空間(152)を有するように変形する
ことを特徴とする血液バッグシステム(10C)。 - 請求項1記載の血液バッグシステム(10、10B、10D~10G)において、
前記延在部(112)と前記収容部(114、140、142、160、170、180、190)は一体成形されている
ことを特徴とする血液バッグシステム(10、10B、10D~10G)。 - 請求項1~4のいずれか1項に記載の血液バッグシステム(10、10A~10G)において、
前記血液用バッグ(14)及び前記チューブ(22)は、前記遠心力の付与時にカセット(34)に取り付けられ、
前記延在部(112)及び前記収容部(114、130、140、142、150、160、170、180、190)は、前記カセット(34)により水平方向に保持されている
ことを特徴とする血液バッグシステム(10、10A~10G)。
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2013/060484 WO2014162592A1 (ja) | 2013-04-05 | 2013-04-05 | 血液バッグシステム |
US14/779,094 US9820912B2 (en) | 2013-04-05 | 2013-04-05 | Blood bag system |
JP2015509837A JP5977444B2 (ja) | 2013-04-05 | 2013-04-05 | 血液バッグシステム |
CN201380075239.9A CN105120912B (zh) | 2013-04-05 | 2013-04-05 | 血液袋系统 |
EP13880921.5A EP2982393B1 (en) | 2013-04-05 | 2013-04-05 | Blood bag system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2013/060484 WO2014162592A1 (ja) | 2013-04-05 | 2013-04-05 | 血液バッグシステム |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014162592A1 true WO2014162592A1 (ja) | 2014-10-09 |
Family
ID=51657918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2013/060484 WO2014162592A1 (ja) | 2013-04-05 | 2013-04-05 | 血液バッグシステム |
Country Status (5)
Country | Link |
---|---|
US (1) | US9820912B2 (ja) |
EP (1) | EP2982393B1 (ja) |
JP (1) | JP5977444B2 (ja) |
CN (1) | CN105120912B (ja) |
WO (1) | WO2014162592A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018062211A1 (en) | 2016-09-30 | 2018-04-05 | Terumo Kabushiki Kaisha | Blood bag system and blood treatment method |
JP6805393B1 (ja) * | 2019-03-19 | 2020-12-23 | テルモ株式会社 | 血液バッグシステム |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016134317A1 (en) | 2015-02-20 | 2016-08-25 | Terumo Bct, Inc. | Composite liquid bag system holder |
WO2018102823A1 (en) | 2016-12-02 | 2018-06-07 | Terumo Bct, Inc | Composite fluid separation |
RU180533U1 (ru) * | 2017-03-21 | 2018-06-15 | Федеральное государственное бюджетное учреждение "Российский научно-исследовательский институт гематологии и трансфузиологии Федерального медико-биологического агентства" (ФГБУ РосНИИГТ ФМБА России) | Контейнер для жидкостей, применяющихся при криоконсервировании и отмывании эритроцитов |
CN108144141A (zh) * | 2017-12-29 | 2018-06-12 | 武汉佰美斯医疗科技有限公司 | 一种无菌接驳设备 |
CN112472893A (zh) * | 2019-09-12 | 2021-03-12 | 费森尤斯医疗护理德国有限责任公司 | 用于将浓缩物容器与血液处理装置连接的系统和方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02167173A (ja) * | 1988-01-29 | 1990-06-27 | Terumo Corp | 血液採取容器及びこれを利用した血液成分分離器具 |
US6910998B2 (en) | 2000-12-29 | 2005-06-28 | Andreas Hettich Gmbh & Co. Kg | Centrifuge comprising a blood bag system with an upper and lower outlet |
JP2009542308A (ja) * | 2006-06-29 | 2009-12-03 | クリップ コンサルタンシー ビー.ヴイ. | 体液用容器システムを備える装置 |
JP2010528740A (ja) * | 2007-06-05 | 2010-08-26 | テルモ ヨーロッパ エヌ ヴイ | カートリッジおよびカートリッジを有する遠心分離器 |
JP2012510298A (ja) * | 2008-11-28 | 2012-05-10 | テルモ株式会社 | 血液バッグシステム及びカセット |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE318625T1 (de) | 1999-03-15 | 2006-03-15 | Implant Innovations Inc | Sammelsystem für thrombozyten |
EP1749546A1 (en) * | 1999-10-01 | 2007-02-07 | Gambro, Inc. | Extracorporeal blood processing methods |
CN2404592Y (zh) * | 1999-12-08 | 2000-11-08 | 郝力 | 液体密封离心罐 |
CN1354021A (zh) * | 2000-11-22 | 2002-06-19 | 巴克斯特国际公司 | 一次性流体处理管路和分离系统 |
JP4297767B2 (ja) * | 2003-01-28 | 2009-07-15 | テルモ株式会社 | 血液処理フィルターシステム |
JP4527425B2 (ja) * | 2004-03-19 | 2010-08-18 | 日本赤十字社 | 自律神経活動モニター装置、血液処理装置および採血装置 |
JP2009540841A (ja) | 2006-06-30 | 2009-11-26 | フラウンホッファー−ゲゼルシャフト ツァ フェルダールング デァ アンゲヴァンテン フォアシュンク エー.ファオ | 高濃度植物タンパク製剤及びその製造方法 |
CN102215888B (zh) | 2008-11-28 | 2014-02-05 | 泰尔茂株式会社 | 血袋系统和固定盒 |
-
2013
- 2013-04-05 CN CN201380075239.9A patent/CN105120912B/zh active Active
- 2013-04-05 EP EP13880921.5A patent/EP2982393B1/en active Active
- 2013-04-05 WO PCT/JP2013/060484 patent/WO2014162592A1/ja active Application Filing
- 2013-04-05 JP JP2015509837A patent/JP5977444B2/ja active Active
- 2013-04-05 US US14/779,094 patent/US9820912B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02167173A (ja) * | 1988-01-29 | 1990-06-27 | Terumo Corp | 血液採取容器及びこれを利用した血液成分分離器具 |
US6910998B2 (en) | 2000-12-29 | 2005-06-28 | Andreas Hettich Gmbh & Co. Kg | Centrifuge comprising a blood bag system with an upper and lower outlet |
JP2009542308A (ja) * | 2006-06-29 | 2009-12-03 | クリップ コンサルタンシー ビー.ヴイ. | 体液用容器システムを備える装置 |
JP2010528740A (ja) * | 2007-06-05 | 2010-08-26 | テルモ ヨーロッパ エヌ ヴイ | カートリッジおよびカートリッジを有する遠心分離器 |
JP2012510298A (ja) * | 2008-11-28 | 2012-05-10 | テルモ株式会社 | 血液バッグシステム及びカセット |
Non-Patent Citations (1)
Title |
---|
See also references of EP2982393A4 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018062211A1 (en) | 2016-09-30 | 2018-04-05 | Terumo Kabushiki Kaisha | Blood bag system and blood treatment method |
JP2019532692A (ja) * | 2016-09-30 | 2019-11-14 | テルモ株式会社 | 血液バッグシステム及び血液処理方法 |
JP6805393B1 (ja) * | 2019-03-19 | 2020-12-23 | テルモ株式会社 | 血液バッグシステム |
Also Published As
Publication number | Publication date |
---|---|
EP2982393A4 (en) | 2016-11-30 |
EP2982393A1 (en) | 2016-02-10 |
JP5977444B2 (ja) | 2016-08-24 |
JPWO2014162592A1 (ja) | 2017-02-16 |
US20160045394A1 (en) | 2016-02-18 |
US9820912B2 (en) | 2017-11-21 |
CN105120912A (zh) | 2015-12-02 |
EP2982393B1 (en) | 2023-02-15 |
CN105120912B (zh) | 2017-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5977444B2 (ja) | 血液バッグシステム | |
JP5695574B2 (ja) | 血液バッグシステム及び血液処理方法 | |
JP5223006B2 (ja) | 血液バッグシステム及びカセット | |
JP5801301B2 (ja) | クランプおよび血液バッグシステム | |
JP5223007B2 (ja) | 血液バッグシステム及びカセット | |
US10518021B2 (en) | Composite liquid bag system holder | |
JP6218873B2 (ja) | クランプおよび血液バッグシステム | |
US20160317727A1 (en) | Blood Bag System and Tube Holder | |
JP6943952B2 (ja) | 血液バッグシステム及び血液処理方法 | |
JP6672262B2 (ja) | 遠心分離機及びセグメント保持部 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13880921 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2015509837 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013880921 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14779094 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |